13F

Stock

vTv Therapeutics Inc.

VTVT · held by 27 managers

Reported value

$51.3M

Holders

27

+0 new · −0 exited

Holders’ est. mark

$12.4K

Price effect on 2 books still in the name

Largest holder

$11.9M

SAMSARA BIOCAPITAL, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
SAMSARA BIOCAPITAL, LLC298.5K$11.9MHeld
Fidelity268.9K$10.8MHeld
Trails Edge Capital Partners, LP231K$9.24MHeld
Siren, L.L.C.163K$6.52MHeld
BAKER BROS. ADVISORS LP148.3K$5.93MHeld
Vanguard83.4K$3.34MHeld
GEODE CAPITAL MANAGEMENT, LLC28.2K$1.13MHeld
683 Capital Management, LLC18.3K$730.5KHeld
NORTHERN TRUST CORP16.1K$641.9KHeld
BlackRock, Inc.10.6K$424.1KHeld
Pathstone Holdings, LLC6.07K$242.9KHeld
GOLDMAN SACHS GROUP INC5.53K$221.2KHeld
UBS Group AG1.67K$66.7KHeld
Tower Research Capital LLC (TRC)1.27K$50.7KHeld
OSAIC HOLDINGS, INC.1.12K$44.8KHeld
MORGAN STANLEY977$39.1K$12.4KAdded$21.7K
Farther Finance Advisors, LLC279$11.2KHeld
CITIGROUP INC244$9.76KHeld
Activest Wealth Management50$2KHeld
CoreCap Advisors, LLC45$1.8KHeld
Parallel Advisors, LLC38$1.52KHeld
Sunbelt Securities, Inc.15$600Held
BNP PARIBAS FINANCIAL MARKETS9$360Held
BANK OF AMERICA CORP /DE/4$160$17Added$137
SBI Securities Co., Ltd.2$80Held
Strategic Wealth Partners, Ltd.1$40Held
BESSEMER GROUP INC112$4Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.